|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients-results of a phase Ⅱ study显示文摘 | Steinbild S Arends J Medinger M | 2007 | Onkologie2007，30，12： | 1 |
| 2 | A phase I dose-escalation study of regorafenib ( BAY 73-4506 ) , an inhibitor of oneogenie, angiogenic, and stromal kinases, in patients with advanced solid tumors 显示文摘 | Mross K Frost A Steinbild S | 2012 | Clin Cancer Res2012，18，9： | 1 |
| 3 | Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients-results of a phase Ⅱ study 显示文摘 | Steinbild S Arends J Medinger M | 2007 | Onkologie2007，30，12： | 1 |
| 4 | Metronomic antiangio-genic therapy with capecitabine and cclecoxib in advanced tumorpatientsresults of a phase 11 study 显示文摘 | Steinbild S Arends J MedingerM | 2007 | Onkologie2007，30，12： | 1 |
| 5 | A phase I doseescalation study of regorafenib (BAY 73-4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors 显示文摘 | Mross K Frost A Steinbild S | 2012 | Clin Cancer Res2012，18，9： | 1 |
| 6 | A phase I dose - escalation study of regorafenib ( BAY 73 -4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors 显示文摘 | MROSS K FROST A STEINBILD S | 2012 | Clin Cancer Res2012，18，9： | 1 |
| 7 | Metronomic antiangiogenie therapy with capeeitahine and celecoxib in advanced tumor patients--results of a phase Ⅱ study 显示文摘 | Steinbild S Arends J Medinger M | 2007 | Onkologie2007，30，12： | 1 |
| 8 | Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenib显示文摘 | Mross K Steinbild S Baas F | 2007 | EurJ Cancer2007，43，1： | 1 |
| 9 | Metmnomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients results of a phase II study显示文摘 | Steinbild S Arends J Medinger M | 2007 | Onkologie2007，30，12： | 1 |
| 10 | Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients results of a phase Ⅱ study显示文摘 | Steinbild S Arends J Medinger M | 2007 | Onkologie2007，30，12： | 1 |
| 11 | Metronomic antiangio- genic therapy with capecitabine and celecoxib in advanced tumor pa- tients-results of a phase I1 study 显示文摘 | Steinbild S Arends J Medinger M | 2007 | Onkologie2007，30，12： | 1 |
| 12 | A clinical phase study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research- EWIV显示文摘 | STEINBILD S MROSS K FROST A | 2007 | Br J Cancer2007，97，11： | 1 |
| 13 | Metronomic anti-angiogenic therapy with capecitabine and celeeoxib in advanced tumor patients-results of a phase II study显示文摘 | STEINBILD S ARENDS J MEDINQER M | 2007 | Onkologie2007，30，12： | 1 |
| 14 | Drug-drug interaction pharmacokinetic study with the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with irinotecan (CPT-11) in patients with solid tumors 显示文摘 | Mross K Steinbild S Baas F | 2003 | Int J Clin Pharmacol Ther2003，41，： | 1 |
| 15 | Phase Ⅰ dose escalation and pharmacokinetic study of BI 2536,a novel Polo-like kinase 1 inhibitor,in patients with advanced solid tumors显示文摘 | Mross K Frost A Steinbild S | 2008 | J Clin Oncol2008，26，34： | 1 |
| 16 | Adjuvant and palliative anticancer treatment of colon carcinoma in 2004 显示文摘 | Medinger M Steinbild S Mross K | 2004 | Schweiz Rundsch Med Prax2004，93，40： | 1 |
| 17 | Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenib显示文摘 | MROSS K STEINBILD S BAAS F | 2007 | Eur J Cancer2007，43，1： | 1 |
| 18 | A phase I dose-escalation study of regorafenib ( BAY 73-4506), an inhibitor of oncogenic, angiogen- ic, and stromal kinases, in patients with advanced solid tumors 显示文摘 | Mross K Frost A Steinbild S | 2012 | Clin Cancer Res2012，18，9： | 1 |
| 19 | Phase II study of sorafenib in hormone refractory patientswith prostate cancer:A study of the central European society for anti- cancer drug research-EW IV(CESAR)显示文摘 | Steinbild S Mross K Morant D | 2006 | J Clin Oncol2006，24，18： | 1 |
| 20 | Adjuvant and palliativeanticancer treatment of colon carcinoma in 2004 显示文摘 | Medinger M Steinbild S Mross K | 2004 | Praxis (Bern1994)2004，93，40： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员